{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:11:07Z","timestamp":1793448667791,"version":"4.5.0"},"reference-count":39,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.3892\/ijo.2015.3213","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T04:57:59Z","timestamp":1445317079000},"page":"2073-2081","source":"Crossref","is-referenced-by-count":64,"title":["Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation"],"prefix":"10.3892","volume":"47","author":[{"given":"TOSHIKI","family":"MAWATARI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ITASU","family":"NINOMIYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAFUMI","family":"INOKUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHINICHI","family":"HARADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIRONORI","family":"HAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KATSUNOBU","family":"OYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ISAMU","family":"MAKINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HISATOSHI","family":"NAKAGAWARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMOHARU","family":"MIYASHITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEHIRO","family":"TAJIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYUKI","family":"TAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SACHIO","family":"FUSHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TETSUO","family":"OHTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"key20180107191131_b1-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107191131_b2-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3748\/wjg.v8.i3.400","article-title":"Effects of histone acetylation and DNA methylation on p21(WAF1) regulation","volume":"8","author":"Fang","year":"2002","journal-title":"World J Gastroenterol"},{"key":"key20180107191131_b3-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"key20180107191131_b4-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i3-4.70","article-title":"Control of chromatin remodeling","volume":"10","author":"Davie","year":"2000","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"key20180107191131_b5-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107191131_b6-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2004.10.001","article-title":"Histone deacetylase inhibitors","volume":"40","author":"Monneret","year":"2005","journal-title":"Eur J Med Chem"},{"key":"key20180107191131_b7-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jb\/mvn074","article-title":"Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo","volume":"144","author":"Sami","year":"2008","journal-title":"J Biochem"},{"key":"key20180107191131_b8-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kr\u00e4mer","year":"2003","journal-title":"EMBO J"},{"key":"key20180107191131_b9-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20180107191131_b10-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1158\/1535-7163.MCT-05-0480","article-title":"Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells","volume":"5","author":"Hrzenjak","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"key20180107191131_b11-ijo-47-06-2073","first-page":"1139","article-title":"p21Waf1\/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells","volume":"13","author":"Rocchi","year":"2005","journal-title":"Oncol Rep"},{"key":"key20180107191131_b12-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.2174\/092986707782023299","article-title":"Human endometrial and ovarian cancer cells: Histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis","volume":"14","author":"Takai","year":"2007","journal-title":"Curr Med Chem"},{"key":"key20180107191131_b13-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnci\/94.7.504","article-title":"Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228","volume":"94","author":"Yu","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"key20180107191131_b14-ijo-47-06-2073","first-page":"937","article-title":"Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity","volume":"1","author":"Blagosklonny","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"key20180107191131_b15-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1677\/ERC-07-0096","article-title":"Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines","volume":"14","author":"Catalano","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"key20180107191131_b16-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2007.10.006","article-title":"Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells","volume":"259","author":"Fortunati","year":"2008","journal-title":"Cancer Lett"},{"key":"key20180107191131_b17-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biocel.2008.08.019","article-title":"Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status","volume":"41","author":"Travaglini","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107191131_b18-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-1085-x","article-title":"VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin","volume":"361","author":"Zhang","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"key20180107191131_b19-ijo-47-06-2073","first-page":"5126","article-title":"Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells","volume":"63","author":"Nimmanapalli","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107191131_b20-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"key20180107191131_b21-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"26729","DOI":"10.1074\/jbc.C500186200","article-title":"Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors","volume":"280","author":"Bali","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107191131_b22-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1158\/1078-0432.CCR-05-0344","article-title":"Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2","volume":"11","author":"Bali","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107191131_b23-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of gluco-corticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol Cell"},{"key":"key20180107191131_b24-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4161\/cc.8.4.7583","article-title":"Death by chaperone: HSP90, HSP70 or both?","volume":"8","author":"Powers","year":"2009","journal-title":"Cell Cycle"},{"key":"key20180107191131_b25-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/153537020322800201","article-title":"Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery","volume":"228","author":"Pratt","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20180107191131_b26-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes Dev"},{"key":"key20180107191131_b27-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"key":"key20180107191131_b28-ijo-47-06-2073","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Cancer Res"},{"issue":"Suppl","key":"key20180107191131_b29-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1471-4914(02)02316-X","article-title":"Hsp90 inhibitors as novel cancer chemotherapeutic agents","volume":"8","author":"Neckers","year":"2002","journal-title":"Trends Mol Med"},{"key":"key20180107191131_b30-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1002\/jcp.24043","article-title":"Scriptaid effects on breast cancer cell lines","volume":"227","author":"Giacinti","year":"2012","journal-title":"J Cell Physiol"},{"key":"key20180107191131_b31-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mce.2003.10.032","article-title":"Antiepileptic drugs inhibit cell growth in the human breast cancer cell line MCF7","volume":"213","author":"Olsen","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107191131_b32-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2867-6-2","article-title":"Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines","volume":"6","author":"Chavez-Blanco","year":"2006","journal-title":"Cancer Cell Int"},{"key":"key20180107191131_b33-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-006-9459-6","article-title":"Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells","volume":"105","author":"Hodges-Gallagher","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107191131_b34-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4238\/2012.January.13.1","article-title":"Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression","volume":"11","author":"Li","year":"2012","journal-title":"Genet Mol Res"},{"key":"key20180107191131_b35-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1158\/0008-5472.CAN-09-2146","article-title":"HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression","volume":"69","author":"Huang","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107191131_b36-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2007.03.076","article-title":"FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70","volume":"356","author":"Wang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107191131_b37-ijo-47-06-2073","first-page":"971","article-title":"Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B","volume":"2","author":"Fuino","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"key20180107191131_b38-ijo-47-06-2073","first-page":"385","article-title":"Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen","volume":"1","author":"Scott","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"key20180107191131_b39-ijo-47-06-2073","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11010-010-0651-y","article-title":"Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90","volume":"348","author":"Meng","year":"2011","journal-title":"Mol Cell Biochem"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3213\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T14:16:22Z","timestamp":1515334582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,10,20]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.3892\/ijo.2015.3213"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3213","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}